CSL Behring has been honored with this prestigious award recognizing innovation and excellence in pharmaceutical facility projects, as the FOYA program celebrates its 20 th anniversary "As FOYA marks ...
CSL Behring setzt auf dynamische Prozesssimulation gekoppelt mit Live-Produktionsdaten für robustere Abläufe und höhere ...
MELBOURNE, Aug. 18, 2025 /PRNewswire/ -- Global biotherapeutics leader CSL today announced a reported net profit after tax of US$3.0 billion for the 12 months ended 30 June 2025, up 17% on a constant ...
Want a feel-good side gig that requires no work, no skill and no experience? Consider plasma donation through CSL Plasma. It’s a lot like giving blood, but you get paid — sometimes generously. CSL ...
Dublin, April 16, 2025 (GLOBE NEWSWIRE) -- The "U.S. Plasma Derived Therapies Market: 2025-2035" report has been added to ResearchAndMarkets.com's offering. The U.S. Plasma-Derived Therapies Market is ...
CSL is one of three tier one plasma therapy companies who benefit from an oligopoly in this highly consolidated market. All the players are vertically integrated as plasma sourcing is the most ...
Hosted on MSN
CSL to pump $1.5bn into US plasma supply chain
CSL will outlay $1.5bn over the next five years in the US to grow its footprint of plasma therapy production, the latest pharma company to pour money into the country amid tariff threats.
Pharmaceuticals company CSL on Tuesday reported a 3% rise in first-half profit, benefiting from further growth in its main blood-plasma business. Australia-based CSL, which runs a network of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results